Background
We have collaborated with an international producation organisation for which we firm provided a valuation of biological assets, ensuring a robust foundation for their make-or-buy sourcing decisions. This support has enabled our client to secure and optimize their raw material supply chain effectively while informing their investment committe on this difficult topic.
Our impact
We developed a sophisticated valuation model, which played a crucial role in crafting a winning bid that met the company’s return requirements. Our analysis detailed the sum of parts of various value drivers, enabling informed decision-making. Additionally, we prepared and presented these findings to the client’s steering and investment committee, further facilitating strategic alignment and informed oversight.